Patients’ Generic-Drug Lawsuits Questioned by High Court

The U.S. Supreme Court grappled with the limits on patients’ lawsuits against drugmakers, questioning a $21 million award to a woman who suffered debilitating injuries after taking a painkiller.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.